The impact of COVID-19 on cancer patients
D Wekking, TH Senevirathne, JL Pearce… - Cytokine & Growth …, 2023 - Elsevier
The COVID-19 pandemic poses a significant challenge for individuals with compromised
immune systems, such as patients with cancer, as they face a heightened susceptibility to …
immune systems, such as patients with cancer, as they face a heightened susceptibility to …
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
More than 3 years have passed since Coronavirus disease 2019 (COVID‐19) was declared
a global pandemic, yet COVID‐19 still severely impacts immunocompromised individuals …
a global pandemic, yet COVID‐19 still severely impacts immunocompromised individuals …
Structural insights for neutralization of Omicron variants BA. 1, BA. 2, BA. 4, and BA. 5 by a broadly neutralizing SARS-CoV-2 antibody
In this study, by characterizing several human monoclonal antibodies (mAbs) isolated from
single B cells of the COVID-19–recovered individuals in India who experienced ancestral …
single B cells of the COVID-19–recovered individuals in India who experienced ancestral …
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
Background Few studies have compared SARS-CoV-2 vaccine immunogenicity by ethnic
group. We sought to establish whether cellular and humoral immune responses to SARS …
group. We sought to establish whether cellular and humoral immune responses to SARS …
[HTML][HTML] Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment
E Su, S Fischer, R Demmer-Steingruber, S Nigg… - ESMO open, 2022 - Elsevier
Background Patients with cancer are at high risk for severe coronavirus disease 2019
(COVID-19) infection. Knowledge regarding the efficacy of the messenger RNA (mRNA) …
(COVID-19) infection. Knowledge regarding the efficacy of the messenger RNA (mRNA) …
[HTML][HTML] Frequently asked questions on coronavirus disease 2019 vaccination for hematopoietic cell transplantation and chimeric antigen receptor T-cell recipients …
F Khawaja, G Papanicolaou, S Dadwal… - … and cellular therapy, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised …
syndrome coronavirus 2 (SARS-CoV-2), disproportionately affects immunocompromised …
BA. 5 bivalent booster vaccination enhances neutralization of XBB. 1.5, XBB. 1.16 and XBB. 1.9 variants in patients with lung cancer
RM Valanparambil, L Lai, MA Johns, M Davis-Gardner… - npj Vaccines, 2023 - nature.com
This study reports that most patients with NSCLC had a significant increase in the nAb
response to the currently circulating Omicron variants after bivalent booster vaccination and …
response to the currently circulating Omicron variants after bivalent booster vaccination and …
[HTML][HTML] SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients
H Geinitz, E Silberberger, K Spiegl, J Feichtinger… - Vaccine, 2024 - Elsevier
Background SARS-CoV-2 infection has been and, in some parts, still is a threat to oncologic
patients, making it crucial to understand perception of vaccination and immunologic …
patients, making it crucial to understand perception of vaccination and immunologic …
Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA. 1 and subvariants BA. 4/5 and BQ. 1.1 after COVID-19 …
O Overheu, S Lendowski, DR Quast, D Kühn… - Journal of Cancer …, 2023 - Springer
Abstract Purpose The SARS-CoV-2 Omicron variant of concern (VOC) and subvariants like
BQ. 1.1 demonstrate immune evasive potential. Little is known about the efficacy of booster …
BQ. 1.1 demonstrate immune evasive potential. Little is known about the efficacy of booster …
Immune responses and reinfection of SARS‐CoV‐2 Omicron variant in patients with lung cancer
C Chen, X Zhou, X Gao, R Pan, Q He… - … Journal of Cancer, 2024 - Wiley Online Library
A significant Omicron wave emerged in China in December 2022. To explore the duration of
humoral and cellular response postinfection and the efficacy of hybrid immunity in …
humoral and cellular response postinfection and the efficacy of hybrid immunity in …